|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||3.95 - 4.10|
|52 Week Range||3.85 - 6.39|
|PE Ratio (TTM)||-10.26|
|Earnings Date||Aug 15, 2017 - Aug 21, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||6.25|
Varian Medical Systems’ (VAR) oncology business reaches around the globe. With a market share of ~60%, It is a leading player in the space. Other major medical device companies in the…
SUNNYVALE, Calif. , Aug. 14, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2017 ended June 30, 2017 on Tuesday, August 22, 2017 after ...
SUNNYVALE, Calif., Aug. 4, 2017 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today that the first studies validating the benefits of the leading-edge Radixact™ System were presented at the 59th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in Denver, Colorado, July 30 through August 3, 2017. This smart radiation therapy system represents the next generation in TomoTherapy® treatment delivery, significantly increasing treatment speed and ease of use. The Radixact System enables clinicians to treat a wide range of cancer cases, from initial plan delivery to adaptive therapy to complex retreatments, with precision and increased efficiency.